Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. In this report, we mainly focus on the Epinephrine Auto-injector and Epinephrine Prefilled Syringe.
This report contains market size and forecasts of Epinephrine in global, including the following market information:
Global Epinephrine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Epinephrine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Epinephrine companies in 2021 (%)
The global Epinephrine market was valued at 3124.9 million in 2021 and is projected to reach US$ 4950.9 million by 2028, at a CAGR of 6.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epinephrine Auto-injector Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epinephrine include Mylan Inc, Impax, ALK Abello, Lincoln Medical, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Epinephrine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epinephrine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Epinephrine Market Segment Percentages, by Type, 2021 (%)
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Global Epinephrine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Epinephrine Market Segment Percentages, by Application, 2021 (%)
Anaphylaxis
Cardiac Arrest
Others
Global Epinephrine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Epinephrine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epinephrine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Epinephrine revenues share in global market, 2021 (%)
Key companies Epinephrine sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Epinephrine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan Inc
Impax
ALK Abello
Lincoln Medical
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao

LEAVE A REPLY

Please enter your comment!
Please enter your name here